|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Property and other revenues | |||||
| Resident fee income | |||||
| Rental income | |||||
| Other revenue | |||||
| Total property and other revenues | |||||
| Interest income on debt investments | |||||
| Expenses | |||||
| Property operating expenses | |||||
| Interest expense | |||||
| Transaction costs | |||||
| Asset management fees - related party | |||||
| General and administrative expenses | |||||
| Depreciation and amortization | |||||
| Impairment loss | |||||
| Total expenses | |||||
| Other income (expense) | |||||
| Other income (expense), net | |||||
| Gain (loss) on investments and other | |||||
| Income (loss) before equity in earnings (losses) of unconsolidated ventures and income tax expense | |||||
| Equity in earnings (losses) of unconsolidated ventures | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Net (income) loss attributable to non-controlling interests | |||||
| Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders | |||||
| Net income (loss) per share of common stock, basic (in dollars per share) | |||||
| Net income (loss) per share of common stock, diluted (in dollars per share) | |||||
| Weighted average number of shares of common stock outstanding, basic (in shares) | |||||
| Weighted average number of shares of common stock outstanding, diluted (in shares) | |||||
| Distributions declared per share of common stock (in dollars per share) | |||||
| Number of shares granted to independent directors (in shares) | |||||
Loading...